Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

GM-CSF receptor antagonist

EU orphan designation number: EU/3/02/089
Active ingredient: GM-CSF receptor antagonist
Indication: Treatment of juvenile myelomonocytic leukaemia
Sponsor: British Biotech Pharmaceuticals Ltd
Watlington road, Oxford, OX4 6LY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/03/2002 Orphan designation EMEA/OD/075/01 (2002)1231 of 18/03/2002
30/09/2002 Removal of orphan designation from Community Register